Adaptive Biotechnologies Announces Business Update Conference Call and Webcast Scheduled for April 2, 2024

Revolutionizing Diagnosis and Treatment with Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corporation, a biotechnology company listed on the Nasdaq under the ticker symbol ADPT, is focused on translating the genetics of the adaptive immune system into clinical products for diagnosing and treating diseases. The company recently announced that it will be hosting a business update conference call and webcast on Tuesday, April 2, 2024, after the market closes at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Adaptive Biotechnologies is dedicated to harnessing the power of the adaptive immune system to revolutionize disease diagnosis and treatment. The company believes that this powerful tool has not been fully utilized due to challenges in decoding it, but its immune medicine platform enables precise and speedy decoding of its genetics at scale. Through collaborations with biopharmaceutical companies, Adaptive Biotechnologies informs drug development and develops clinical diagnostics in two main areas: Minimal Residual Disease (MRD) and Immune Medicine. Their products and pipeline aid in diagnosing, monitoring, and treating diseases such as cancer, autoimmune disorders, and infectious diseases with the goal of developing personalized immune-driven clinical products for each patient.

Investors can reach out to Karina Calzadilla, Vice President of Investor Relations at investors@adaptivebiotech.com for any inquiries or contact Erica Jones, Associate Director of Corporate Communications at media@adaptivebiotech.com for media inquiries.

Leave a Reply

Ongoing investigation as Bolsonaro seeks refuge in Hungarian embassy Previous post Exploring the Rise and Fall of Brazilian President Jair Bolsonaro: A Two-Night Stay at the Hungarian Embassy in Brasilia
Cease Utilizing the Sahm Rule Recession Indicator for States Next post Alarm Bells: 20 States on Recession Watch as Unemployment Rates Soar